Abstract:Inflammasomes are intracellular multiprotein complexes that activate inflammatory signaling pathways. Inflammasomes comprise two major classes: canonical inflammasomes, which were discovered first and are activated in response to a variety of pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs), and non-canonical inflammasomes, which were discovered recently and are only activated in response to intracellular lipopolysaccharide (LPS). Although a larger number of studies have successfully demonstrated that canonical inflammasomes, particularly the NLRP3 inflammasome, play roles in various rheumatic diseases, including rheumatoid arthritis (RA), infectious arthritis (IR), gouty arthritis (GA), osteoarthritis (OA), systemic lupus erythematosus (SLE), psoriatic arthritis (PA), ankylosing spondylitis (AS), and Sjögren's syndrome (SjS), the regulatory roles of non-canonical inflammasomes, such as mouse caspase-11 and human caspase-4 non-canonical inflammasomes, in these diseases are still largely unknown. Interestingly, an increasing number of studies have reported possible roles for non-canonical inflammasomes in the pathogenesis of various mouse models of rheumatic disease. This review comprehensively summarizes and discusses recent emerging studies demonstrating the regulatory roles of non-canonical inflammasomes, particularly focusing on the caspase-11 non-canonical inflammasome, in the pathogenesis and progression of various types of rheumatic diseases and provides new insights into strategies for developing potential therapeutics to prevent and treat rheumatic diseases as well as associated diseases by targeting non-canonical inflammasomes.

Regulation, Activation and Function of Caspase-11 during Health and Disease

Regulatory Roles of the Caspase-11 Non-Canonical Inflammasome in Inflammatory Diseases

The Role of Caspase-11 in the Immune Inflammatory Response

Non-canonical inflammasome activation targets caspase-11

Caspase-1: The inflammasome and beyond

Caspase-11, a specific sensor for intracellular lipopolysaccharide recognition, mediates the non-canonical inflammatory pathway of pyroptosis

Caspase-11 Controls Interleukin-1Β Release Through Degradation of TRPC1.

Caspase-6 Promotes Activation of the Caspase-11-nlrp3 Inflammasome During Gram-Negative Bacterial Infections.

Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling

Crystal structure of caspase-11 CARD provides insights into caspase-11 activation

Dynamin-related Irgm proteins modulate LPS-induced caspase-11 activation and septic shock

Caspase-5: Structure, Pro-Inflammatory Activity and Evolution

Catalytic activity and autoprocessing of murine caspase-11 mediate noncanonical inflammasome assembly in response to cytosolic LPS

Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock

Human Caspases: Activation, Specificity, and Regulation

Molecular mechanism of pyroptosis and inflammasome activation

Inflammatory caspases are innate immune receptors for intracellular LPS

Caspases Connect Cell-Death Signaling to Organismal Homeostasis

Roles of the Caspase-11 Non-Canonical Inflammasome in Rheumatic Diseases

The tetrapeptide sequence of IL-1β regulates its recruitment and activation by inflammatory caspases

The non-canonical inflammasome activators Caspase-4 and Caspase-5 are differentially regulated during immunosuppression-associated organ damage